BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15933261)

  • 1. Association of a functional polymorphism in the clopidogrel target receptor gene, P2Y12, and the risk for ischemic cerebrovascular events in patients with peripheral artery disease.
    Ziegler S; Schillinger M; Funk M; Felber K; Exner M; Mlekusch W; Sabeti S; Amighi J; Minar E; Brunner M; Müller M; Mannhalter C
    Stroke; 2005 Jul; 36(7):1394-9. PubMed ID: 15933261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease.
    Bierend A; Rau T; Maas R; Schwedhelm E; Böger RH
    Br J Clin Pharmacol; 2008 Apr; 65(4):540-7. PubMed ID: 17995973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C
    Thromb Res; 2005; 116(6):491-7. PubMed ID: 16181985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms.
    Kar R; Meena A; Yadav BK; Yadav R; Kar SS; Saxena R
    Platelets; 2013; 24(4):297-302. PubMed ID: 22721490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome.
    Cuisset T; Frere C; Quilici J; Morange PE; Saut N; Lambert M; Camoin L; Vague IJ; Bonnet JL; Alessi MC
    Thromb Res; 2007; 120(6):893-9. PubMed ID: 17337040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2Y12 receptor gene polymorphism and antiplatelet effect of clopidogrel in patients with coronary artery disease after coronary stenting.
    Zoheir N; Abd Elhamid S; Abulata N; El Sobky M; Khafagy D; Mostafa A
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):525-31. PubMed ID: 23751603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of PON1, P2Y12 and COX1 with Recurrent Ischemic Events in Patients with Extracranial or Intracranial Stenting.
    Li XQ; Ma N; Li XG; Wang B; Sun SS; Gao F; Mo DP; Song LG; Sun X; Liu L; Zhao XQ; Wang YL; Wang YJ; Zhao ZG; Miao ZR
    PLoS One; 2016; 11(2):e0148891. PubMed ID: 26870959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of CYP2C19, P2Y12, and GPIIIa Variants Associates With Efficacy of Clopidogrel and Adverse Events on Patients With Ischemic Stroke.
    Yi X; Wang Y; Lin J; Cheng W; Zhou Q; Wang C
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):761-768. PubMed ID: 27233747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel.
    Lev EI; Patel RT; Guthikonda S; Lopez D; Bray PF; Kleiman NS
    Thromb Res; 2007; 119(3):355-60. PubMed ID: 16581111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of P2Y12-ADP receptor polymorphism on the efficacy of clopidogrel dose-adjustment according to platelet reactivity monitoring in coronary artery disease patients.
    Bonello L; Bonello-Palot N; Armero S; Bonello C; Mokhtar OA; Arques S; Dignat-George F; Camoin-Jau L; Paganelli F
    Thromb Res; 2010 Apr; 125(4):e167-70. PubMed ID: 19914687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carotid artery stenting outcomes: do they correlate with antiplatelet response assays?
    Sorkin GC; Dumont TM; Wach MM; Eller JL; Mokin M; Natarajan SK; Baxter MS; Snyder KV; Levy EI; Hopkins LN; Siddiqui AH
    J Neurointerv Surg; 2014 Jun; 6(5):373-8. PubMed ID: 23794673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet reactivity and clopidogrel resistance are associated with the H2 haplotype of the P2Y12-ADP receptor gene.
    Staritz P; Kurz K; Stoll M; Giannitsis E; Katus HA; Ivandic BT
    Int J Cardiol; 2009 Apr; 133(3):341-5. PubMed ID: 18485500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet receptor Gene (P2Y12, P2Y1) and platelet glycoprotein Gene (GPIIIa) polymorphisms are associated with antiplatelet drug responsiveness and clinical outcomes after acute minor ischemic stroke.
    Yi X; Zhou Q; Wang C; Lin J; Liu P; Fu C
    Eur J Clin Pharmacol; 2017 Apr; 73(4):437-443. PubMed ID: 28091702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The inter-individual variability of the response to clopidogrel].
    Gachet C; Aleil B
    Arch Mal Coeur Vaiss; 2005 Mar; 98(3):216-25. PubMed ID: 15816325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does glycoprotein IIIa gene (Pl(A)) polymorphism influence clopidogrel resistance? : a study in older patients.
    Papp E; Havasi V; Bene J; Komlosi K; Talian G; Feher G; Horvath B; Szapary L; Toth K; Melegh B
    Drugs Aging; 2007; 24(4):345-50. PubMed ID: 17432927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable extent of clopidogrel responsiveness in patients after coronary stenting.
    Grossmann R; Sokolova O; Schnurr A; Bonz A; Porsche C; Obergfell A; Lengenfelder B; Walter U; Eigenthaler M
    Thromb Haemost; 2004 Dec; 92(6):1201-6. PubMed ID: 15583724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the prevalence of aspirin and clopidogrel resistances in patients with coronary artery disease by using various platelet-function tests.
    Woo KS; Kim BR; Kim JE; Goh RY; Yu LH; Kim MH; Han JY
    Korean J Lab Med; 2010 Oct; 30(5):460-8. PubMed ID: 20890076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy.
    Smith SM; Judge HM; Peters G; Armstrong M; Dupont A; Gaussem P; Storey RF
    Platelets; 2005 Sep; 16(6):340-5. PubMed ID: 16194864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.